US3850577A - Rapid extraction method for serum thyroxine - Google Patents

Rapid extraction method for serum thyroxine Download PDF

Info

Publication number
US3850577A
US3850577A US00411517A US41151773A US3850577A US 3850577 A US3850577 A US 3850577A US 00411517 A US00411517 A US 00411517A US 41151773 A US41151773 A US 41151773A US 3850577 A US3850577 A US 3850577A
Authority
US
United States
Prior art keywords
thyroxine
buffer
mixture
serum
serum sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00411517A
Inventor
F Ashkar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to US00411517A priority Critical patent/US3850577A/en
Priority to CA208,122A priority patent/CA1028230A/en
Application granted granted Critical
Publication of US3850577A publication Critical patent/US3850577A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/804Radioisotope, e.g. radioimmunoassay
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/825Pretreatment for removal of interfering factors from sample
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/826Additives, e.g. buffers, diluents, preservatives

Definitions

  • thyroxine binding globulin TSG
  • prealbumin to which binding is of intermediate affinity
  • albumin to which binding is relatively weak.
  • TBG thyroxine binding globulin
  • One of the first in vitro tests which was developed to measure thyroid activity, specifically total serum thyroxine, using the principal of competitive protein binding is described in Clin. Chem. Acta 5:453, 1960 by R. P. Ekins. Ekins extracted the thyroxine from serum by precipitation with butanol. Murphy in Nature, 2015679, 1964 and Murphy and Patee, in Journal Clin. Endocrinology and Metabolism, 242187, 1964 described a more rapid and simple method of total serum thyroxine measurement based on the same principal, which they refer to as competitive protein binding analysis.
  • the competitive protein binding analysis method for the determination of total serum thyroxine is based upon the in vitro competition between thyroxine and tracer l thyroxine for the binding sites of thyroxine binding globulin.
  • the ion exchange resin acts as a secondary binding site for the unbound thyroxine.
  • the ion exchange method measures the amount of thyroxine which becomes irreversibely bound to the resinsponge. This amount depends on the disassociation constant of thyroxine binding with serum proteins, the number of binding sites on the protein, the pH, temperature and incubation time in the test conditions.
  • the competitive protein binding analysis technique requires the use of ethanol to liberate bound thyroxine from serum proteins to make it available for competitive binding.
  • the extraction time for liberating bound thyroxine using ethanol ranges between to 45 minutes and requires anywhere between'3 to 4 steps to achieve an 85 percent extraction efficiency.
  • a simpler and more rapid thyroxine extraction method is therefore desirable since measurement of total thyroxine inserum has become one of the primary in vitro tests for evaluating thyroid function and has gained great acceptance.
  • an acid buffer comprising a glutamate salicylate'mixture is an excellent agent for rapid thyroxine extraction.
  • the buffer comprises a mixture of glutamic acid and sodium salicylate having a pH of 3.5.
  • percent of the thyroxine in the serum will be instantaneously extracted. This is comparable to theextraction efficiency of the conventional alcohol extraction procedure. If the serum-buffer mixture is heated, an extraction efficiency. approaching percent results. It is believed that the acid buffer functions by preventing protein coagulation. Substitution of an acid buffer for the alcohol in the extraction step of the competitive protein binding analysis method has the advantages of speed, simplicity, low cost, fewer steps, greater extraction efficiency and excellent reproducibility.
  • FIG. 4 is a graph illustrating the effect on thyroxine extraction of increasing the amount of buffer with respect to the amount of serum sample.
  • Thyroxine levels were obtained by mixing the serum and buffer mixture with thyroxine'binding globulinfully saturated with labeled thyroxine. After competitive binding had taken place, the bound and free labeled thyroxine were separated by an anionic resin and the percent resin bound F thyroxine was calculated. The final results were obtained by comparing the samples radiometrically to thyroxine standards.
  • EXAMPLE 1 Using the apparatus and method disclosed in U.S. Pat. Nos. 3,206,602 and 3,376,114, 0.5 ml. of buffer was added to 0.1 ml. of serum and the mixture placed in an ice bath for 5 minutes. One milliliter of I"? labeled thyroxine binding globulin reagent was thenadded together with an ion exchange resin-sponge and the mixture incubated in ice water for 1 hour. Using a scintillation counter, the radioactivity of thecom'bined mixture is determined and, after incubation, the fluid is aspirated from the tube and the sponge is washed with water. The radioactivity remaining on the sponge is determined and the percent sponge uptake for each sample is obtained by dividing the final count by the initial count.
  • the spontaneous extraction efficiency of the acid buffer was found to be 85 percent which is comparable to the extraction efficiency of alcohol. When the serumbuffer mixture was boiled, the extraction efficiency approached 100 percent (See FIG. 1). Increasing amount of acid buffer in comparison to the serum sample improved the extraction ability progressively both with and without boiling. Spontaneous extraction did not occur until the volume of buffer exceeded 0,2 ml. and reached the 85 percent extraction efficiency with 0.5 ml. of buffer. Thus optimum extraction was found to occur when 0.1 ml. of serum was mixed with 0.5 ml. of buffer and the mixture boiled for one minute (See FIG. 4). The extraction efficiency of the acid buffer was found to decrease when the buffer was diluted. With heating the extraction efficiency was found to drop to zero when.
  • the extraction efficiency of the acid buffer was found to be consistent in low, normal and elevated thyroxine levels as evidenced by the thyroxine obtained in the case of two hypothyroid, two normal and two hyperthyroid patients as compared to the use of alcohol for the extraction of thyroxine.
  • the ratio of buffer to serum' is preferably maintained from between 1:1 to 5:1.
  • the buffer is preferably used at a concentration of 12 grams per liter of glutamic acid and 0.04 grams per liter of sodium salicylate but is effective down to a dilution of 1:8, the concentration of ingredients ranging from 1:33 to 12 grams per liter of glutamic acid and 0.004 to 0.04 grams per liter of sodium salicylate.
  • the improvement comprising extracting the thyroxine from the thyroxine binding globulin in a serum sample by placing. a bufferin contact with said serum sample, said buffer comprising a glutamate salicylate mixture.
  • said buffer comprises a mixture of glutamic acid and sodium salicylate, the concentration of glutamic acid ranging from about 1:33 to about 12 grams per liter and the concentration of sodium salicylate ranging from about 0.004 to about 0.04 grams per liter.
  • said buffer comprises a mixtureof 12 grams per liter of glutamic acid and 0.04 grams per liter of sodium salicylate.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method for determining total thyroxine by the competitive protein binding analysis procedure and in which an acid buffer is employed to liberate the bond thyroxine from the serum proteins to make the thyroxine available for competitive binding. The buffer greatly reduces extraction time in comparison to the use of alcohol, conventionally used in such procedures, and comprises a glutamate - salicylate mixture.

Description

United States Patent Ashkar [4 Nov. 26, 1974 RAPID EXTRACTION METHOD FOR 3,775,615 11/1973 Eisentraut 23/230 B SERUM THYRQXINE 3,799,740 3/1974 Mincey 23/230 [75] lnventor: Fuad Sa1ame h Ashkar, Miami, Fla.
[73] Assignee: Abbott Laboratories, North Chicago, 111.
[22] Filed: Oct. 31, 1973 [2]] Appl. No.: 411,517
[52] [1.8. CI 23/230 B [51] Int. Cl. G01n 33/16 [58] Field of Search 23/230 B; 424/1 [56] References Cited UNITED STATES PATENTS 3,702,821 11/1972 Fernandez 23/230 B 3,745,211 7/1973 Brown et a1 23/230 B Primary Examiner-R. E. Serwin Attorney, Agent, or Firm-Robert L. Niblack; Gildo E. Fato [57] ABSTRACT dures, and comprises a glutamate salicylate mixture. 2
s C1aims,4 Drawing Figures sum 20F 2 F163 8 THE EFFECT OF BUFFER DILUTIONS on THYROXIHE N l-MINUTE EXTRACTION FROM 6 Bmunq NORMAL SERUM BOI LING! QA 1 i 0 1:2 1:4 1:8 1:16 n32 BUFFER mun-nous I FIG.4-
THE EFFECT 0F 1- MINUTE INCREASING 8 BOlLlNG THE AMOUNT OF EuFFER 0N THYROXI NE EXTRACTION 6 FROM NORMAL I No sERuM Bo lLlNG 4- VOLUME OF BUFFER USED IN MILLILITERS RAPID EXTRACTION METHOD FOR SERUM THYROXINE BACKGROUND OF THE INVENTION The primary function of the thyroid gland is the regulation of cellular metabolism through the synthesis and secretion of two hormones, triiodothyronine (T3) and tetraiodothyronine (thyroxine or T4). These hormones are primarily bound by three plasma proteins once they are secreted from the thyroid. These are thyroxine binding globulin (TBG) to which binding is the strongest; prealbumin to which binding is of intermediate affinity; and albumin to which binding is relatively weak. One of the first in vitro tests which was developed to measure thyroid activity, specifically total serum thyroxine, using the principal of competitive protein binding is described in Clin. Chem. Acta 5:453, 1960 by R. P. Ekins. Ekins extracted the thyroxine from serum by precipitation with butanol. Murphy in Nature, 2015679, 1964 and Murphy and Patee, in Journal Clin. Endocrinology and Metabolism, 242187, 1964 described a more rapid and simple method of total serum thyroxine measurement based on the same principal, which they refer to as competitive protein binding analysis. In this procedure, a single ethanol extraction is used to separate the thyroxine from the serum. Loose anion exchange resin was employed to separate TBG bound I thyroxine from unbound thyroxine. An important requirement in such tests is a simple, quick and reproducible method of separating TBG bound thyroxine from unbound thyroxine after equilibrium has been obtained in test conditions. U.S. Pat. Nos. 3,206,602 and 3,376,1l4 describe a test method and apparatus employing a resin sponge as a means of separating bound from unbound thyroxine. Such resin sponges have finely divided ion exchange resin dispersed within the sponge. Unbound thyroxine is quickly and quantitatively bound to the resinsponge while TBG bound thyroxine is not.
The competitive protein binding analysis method for the determination of total serum thyroxine is based upon the in vitro competition between thyroxine and tracer l thyroxine for the binding sites of thyroxine binding globulin. The ion exchange resin acts as a secondary binding site for the unbound thyroxine. The ion exchange method measures the amount of thyroxine which becomes irreversibely bound to the resinsponge. This amount depends on the disassociation constant of thyroxine binding with serum proteins, the number of binding sites on the protein, the pH, temperature and incubation time in the test conditions. The competitive protein binding analysis technique requires the use of ethanol to liberate bound thyroxine from serum proteins to make it available for competitive binding. The extraction time for liberating bound thyroxine using ethanol ranges between to 45 minutes and requires anywhere between'3 to 4 steps to achieve an 85 percent extraction efficiency. A simpler and more rapid thyroxine extraction method is therefore desirable since measurement of total thyroxine inserum has become one of the primary in vitro tests for evaluating thyroid function and has gained great acceptance. I
SUMMARY OF THE INVENTION It has been found that an acid buffer comprising a glutamate salicylate'mixture is an excellent agent for rapid thyroxine extraction. Preferably, the buffer comprises a mixture of glutamic acid and sodium salicylate having a pH of 3.5. When 0.1 ml. of serum is mixed with 0.5 ml. of the buffer, percent of the thyroxine in the serum will be instantaneously extracted. This is comparable to theextraction efficiency of the conventional alcohol extraction procedure. If the serum-buffer mixture is heated, an extraction efficiency. approaching percent results. It is believed that the acid buffer functions by preventing protein coagulation. Substitution of an acid buffer for the alcohol in the extraction step of the competitive protein binding analysis method has the advantages of speed, simplicity, low cost, fewer steps, greater extraction efficiency and excellent reproducibility.
DRAWINGS tion on thyroxine extraction from normal serum.
FIG. 4 is a graph illustrating the effect on thyroxine extraction of increasing the amount of buffer with respect to the amount of serum sample.
DETAILED DESCRIPTION The substitution of an acid buffer for the alcohol as an extraction agent to liberatebound thyroxine from serum proteins in the competitive protein binding analysis method for determining total serum thyroxine has I been found to produce essentially instanteous extraction. A buffer comprising glutamic acid and sodium salicylate, 12 grams of glutamic acid and 0.04 grams of sodium salicylate per. liter, is preferred. The extraction ability of 0.5 ml. of this buffer was tested using 0.1 ml. of serum and compared to the use of alcohol. The effect of heating as well as increasing the amount of buffer, and buffer dilution were also evaluated. The reproducibility of the buffer in the hypo and hyperthyroid hormone levels was also determined. Thyroxine levels were obtained by mixing the serum and buffer mixture with thyroxine'binding globulinfully saturated with labeled thyroxine. After competitive binding had taken place, the bound and free labeled thyroxine were separated by an anionic resin and the percent resin bound F thyroxine was calculated. The final results were obtained by comparing the samples radiometrically to thyroxine standards.
EXAMPLE 1 Using the apparatus and method disclosed in U.S. Pat. Nos. 3,206,602 and 3,376,114, 0.5 ml. of buffer was added to 0.1 ml. of serum and the mixture placed in an ice bath for 5 minutes. One milliliter of I"? labeled thyroxine binding globulin reagent was thenadded together with an ion exchange resin-sponge and the mixture incubated in ice water for 1 hour. Using a scintillation counter, the radioactivity of thecom'bined mixture is determined and, after incubation, the fluid is aspirated from the tube and the sponge is washed with water. The radioactivity remaining on the sponge is determined and the percent sponge uptake for each sample is obtained by dividing the final count by the initial count.
The spontaneous extraction efficiency of the acid buffer was found to be 85 percent which is comparable to the extraction efficiency of alcohol. When the serumbuffer mixture was boiled, the extraction efficiency approached 100 percent (See FIG. 1). Increasing amount of acid buffer in comparison to the serum sample improved the extraction ability progressively both with and without boiling. Spontaneous extraction did not occur until the volume of buffer exceeded 0,2 ml. and reached the 85 percent extraction efficiency with 0.5 ml. of buffer. Thus optimum extraction was found to occur when 0.1 ml. of serum was mixed with 0.5 ml. of buffer and the mixture boiled for one minute (See FIG. 4). The extraction efficiency of the acid buffer was found to decrease when the buffer was diluted. With heating the extraction efficiency was found to drop to zero when. the dilution reached 1:8, while with the heating technique, the efficiency dropped to a plateau after a 1:8 dilution. The extraction efficiency of the acid buffer was found to be consistent in low, normal and elevated thyroxine levels as evidenced by the thyroxine obtained in the case of two hypothyroid, two normal and two hyperthyroid patients as compared to the use of alcohol for the extraction of thyroxine.
As is apparent from FIG. 4, using 0.1 ml. of serum, the ratio of buffer to serum' is preferably maintained from between 1:1 to 5:1. Likewise, (see FIG. 3) the buffer is preferably used at a concentration of 12 grams per liter of glutamic acid and 0.04 grams per liter of sodium salicylate but is effective down to a dilution of 1:8, the concentration of ingredients ranging from 1:33 to 12 grams per liter of glutamic acid and 0.004 to 0.04 grams per liter of sodium salicylate.
What is claimed is:
1. In a method of determining the total serum thyroxine in a serum sample, said method comprising:
extracting the thyroxine. from the thyroxine binding globulin in the serum sample;
mixing a tracer amount of thyroxine globulin saturated with radioactively labeled thyroxine with the thyroxine extracted from the thyroxine binding globulin in the serum sample;
placing an ion exchange resin in intimate contact with said mixture; incubating the combined mixture and ion exchange resin;
measuring with suitable detecting means the initial radioactivity of the combined mixture and ion exchange resin;
removing the mixture; and
measuring with suitable detecting means the residual radioactivity in the ion exchange resin;
the improvement comprising extracting the thyroxine from the thyroxine binding globulin in a serum sample by placing. a bufferin contact with said serum sample, said buffer comprising a glutamate salicylate mixture.
2. The'me thod of claim 1 wherein said buffer comprises a mixture of glutamic acid and sodium salicylate, the concentration of glutamic acid ranging from about 1:33 to about 12 grams per liter and the concentration of sodium salicylate ranging from about 0.004 to about 0.04 grams per liter.
3. The method of claim 2 wherein said buffer comprises a mixtureof 12 grams per liter of glutamic acid and 0.04 grams per liter of sodium salicylate.
4. The method of claim 3 wherein the ratio of buffer to serum sample is from 1:1 to 5:1.
v 5. The method of claim 1 wherein the serum-buffer mixture is heated prior to adding the radioactively labeled thyroxine bindingglobulin.

Claims (5)

1. IN A METHOD OF DETERMINATING THE TOTAL SERUM THROXINE IN A SERUM SAMPLE, SAID METHOD COMPRISING: EXTRACTING THE THYROXINE FROM THE GLOBULIN IN THE SERUM WITH IN THE SERUM SAMPLE; MIXING A TRACER AMOUNT OF THYROXINE WITH THE THYROXINE GLOBULIN RADIOACTIVEL LABELLED THROXINE WITH THE THYROXINE TRACTED FROM THE THYROXINE BINDING GLOBULIN IN THE SERUM SAMPLE; PLACING AN ION EXCHANGE RESIN IN INTIMATE CONTACT WITH SAID MIXTURE; INCUBATING THE COMBINED MIXTURE AND ION EXCHANGE RESIN; MEASURING WITH SUITABLE DETECTING MEANS THE INITIAL RADIOACTIVITY OF THE COMBINED MIXTURE AND ION EXCHAGNE RESIN; REMOVING THE MIXTURE AND MEASURING WITH SUITABLE DETECTING MEANS THE RESIDUAL RADIOACTIVITY IN THE ION EXCHANGE RESIN; THE IMPROVEMENT COMPRISING EXTRACTING THE THYROXINE FROM THE THYROXINE BINDING GLOBULIN IN A SERUM SAMPLE BY PLACING A BUFFER IN CONTACT WITH SAID SERUM SAMPLE, SAID BUFFER COMPRISING A GLUTAMATE SALICYLATE MIXTURE.
2. The method of claim 1 wherein said buffer comprises a mixture of glutamic acid and sodium salicylate, the concentration of glutamic acid ranging from about 1.33 to about 12 grams per liter and the concentration of sodium salicylate ranging from about 0.004 to about 0.04 grams per liter.
3. The method of claim 2 wherein said buffer comprises a mixture of 12 grams per liter of glutamic acid and 0.04 grams per liter of sodium salicylate.
4. The method of claim 3 wherein the ratio of buffer to serum sample is from 1:1 to 5:1.
5. The method of claim 1 wherein the serum-buffer mixture is heated prior to adding the radioactively labeled thyroxine binding globulin.
US00411517A 1973-10-31 1973-10-31 Rapid extraction method for serum thyroxine Expired - Lifetime US3850577A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US00411517A US3850577A (en) 1973-10-31 1973-10-31 Rapid extraction method for serum thyroxine
CA208,122A CA1028230A (en) 1973-10-31 1974-08-29 Rapid extraction method for serum thyroxine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00411517A US3850577A (en) 1973-10-31 1973-10-31 Rapid extraction method for serum thyroxine

Publications (1)

Publication Number Publication Date
US3850577A true US3850577A (en) 1974-11-26

Family

ID=23629259

Family Applications (1)

Application Number Title Priority Date Filing Date
US00411517A Expired - Lifetime US3850577A (en) 1973-10-31 1973-10-31 Rapid extraction method for serum thyroxine

Country Status (2)

Country Link
US (1) US3850577A (en)
CA (1) CA1028230A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929981A (en) * 1974-02-27 1975-12-30 Squibb & Sons Inc Method for determining thyroid function
US4066410A (en) * 1975-09-15 1978-01-03 Nuclear-Medical Laboratories, Inc. Thyroid hormone assay
US4081525A (en) * 1976-08-16 1978-03-28 Beckman Instruments, Inc. Radioimmunoassay of plasma steroids
US4086059A (en) * 1975-05-16 1978-04-25 Bio-Rad Laboratories, Inc. Method for the analysis of thyroid hormones
US4121975A (en) * 1976-08-20 1978-10-24 Syva Company Pretreatment of samples for polyiodothyronine assays
US4155711A (en) * 1975-06-24 1979-05-22 Smutko Raymond A Method and apparatus for determining thyroid function of multiple samples
US4311690A (en) * 1978-06-20 1982-01-19 Damon Corporation Test set and method for the determination of free hormones

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3702821A (en) * 1970-12-14 1972-11-14 Bio Chem Procedures Inc Serum thyroxine anion exchange resin
US3745211A (en) * 1971-04-08 1973-07-10 Mallinckrodt Chemical Works Method for determining thyroxine in blood serum and reagent therefor
US3775615A (en) * 1971-07-06 1973-11-27 Nuclear Med Lab Method of determining thyroid function
US3799740A (en) * 1971-07-12 1974-03-26 Mallinckrodt Chemical Works Clinical competitive-binding test methods

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3702821A (en) * 1970-12-14 1972-11-14 Bio Chem Procedures Inc Serum thyroxine anion exchange resin
US3745211A (en) * 1971-04-08 1973-07-10 Mallinckrodt Chemical Works Method for determining thyroxine in blood serum and reagent therefor
US3775615A (en) * 1971-07-06 1973-11-27 Nuclear Med Lab Method of determining thyroid function
US3799740A (en) * 1971-07-12 1974-03-26 Mallinckrodt Chemical Works Clinical competitive-binding test methods

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929981A (en) * 1974-02-27 1975-12-30 Squibb & Sons Inc Method for determining thyroid function
US4086059A (en) * 1975-05-16 1978-04-25 Bio-Rad Laboratories, Inc. Method for the analysis of thyroid hormones
US4155711A (en) * 1975-06-24 1979-05-22 Smutko Raymond A Method and apparatus for determining thyroid function of multiple samples
US4066410A (en) * 1975-09-15 1978-01-03 Nuclear-Medical Laboratories, Inc. Thyroid hormone assay
US4081525A (en) * 1976-08-16 1978-03-28 Beckman Instruments, Inc. Radioimmunoassay of plasma steroids
US4121975A (en) * 1976-08-20 1978-10-24 Syva Company Pretreatment of samples for polyiodothyronine assays
US4311690A (en) * 1978-06-20 1982-01-19 Damon Corporation Test set and method for the determination of free hormones

Also Published As

Publication number Publication date
CA1028230A (en) 1978-03-21

Similar Documents

Publication Publication Date Title
Braverman et al. Evaluation of a simplified technique for the specific measurement of serum thyroxine concentration
US3928553A (en) Radioimmunoassay method for triiodothyronine and thyroxine
US3911096A (en) Radioimmunoassay for measurement of thyroxine (T{HD 4{B ) and triiodothyonine (T{HD 3{B ) in blood serum
US3850577A (en) Rapid extraction method for serum thyroxine
US4157895A (en) RIA reagents and processes
CHOPRA et al. Competitive ligand-binding assay for measurement of thyronine-binding globulin (TBG)
US3799740A (en) Clinical competitive-binding test methods
Beckers et al. Evaluation of serum thyroxine by radioimmunoassay
Rose et al. Plasma thyroid‐stimulating hormone and thyroxine concentrations in breast cancer
Chopra et al. Direct determination of free triiodothyronine (T3) in undiluted serum by equilibrium dialysis/radioimmunoassay (RIA)
Cheung et al. Use of polyethylene glycol in separating bound from unbound ligand in radioimmunoassay of thyroxine.
Roberts et al. Determination of thyroxine-binding globulin: A simplified procedure utilizing dextran-coated charcoal
Sakurada et al. Polyacrylamide gel electrophoretic study on the effect of estrogen on human thyroxine-binding prealbumin
Balabanov et al. Immunoreactive parathyroid hormone, calcium, and magnesium in human cerebrospinal fluid
Cioffi et al. Serum concentration of free t3, free t4, and tsh in healthy children
Hopwood et al. Thyroid antibodies in children and adolescents with thyroid disorders
NAKAMURA et al. Serum thyroglobulin concentration in normal pregnancy
Bluett et al. Simultaneous radioimmunoassay of thyrotropin and thyroxine in human serum.
Dussault et al. Thyroxine-binding globulin capacity and concentration evaluated from blood spots on filter-paper in a screening program for neonatal hypothyroidism
Levine et al. Anomalous serum thyroxin measurements with the abbott TDx procedure
NAKAMURA et al. An improved and simplified method for the detection of thyroid hormone autoantibodies (THAA) in serum
Burman et al. Evaluation of a rapid and simple technique for the radioimmunoassay of triiodothyronine (T3)
Irvine The Significance of Gastric Antibodies: Clinical and Pathological Signifance of Parietal Cell Antibodies
Cuarón et al. The binding of 131I-triiodothyronine by serum proteins as an in vitro test of thyroid function
Badman et al. Assessment of a simple technique for the determination of serum thyroxine